Jardine Cycle & Carriage signals steady 2025 profit as non-Astra units offset weaker flagship contribution

SGX Filings
2025/11/10

Nov, 10 2025 — Jardine Cycle & Carriage Limited said its full-year underlying profit is expected to be “broadly similar” to that of 2024, despite a lower contribution from 50.1%-owned Astra International during the first nine months of 2025.

The company reported that stronger performances from several non-Astra businesses and favourable translation gains on corporate loans mitigated the impact of a weaker Indonesian Rupiah on Astra’s earnings.

Astra logged reduced underlying profit for the nine-month period, as lower coal prices and weather-related disruptions weighed on heavy equipment and mining, while automotive operations saw softer new-car sales and stable motorcycle share. Higher earnings from financial services, agribusiness and infrastructure partly offset those declines.

Astra completed the acquisition of an 83.7% stake in logistics property developer Mega Manunggal Property, raised its holding in Hermina Hospital to 20%, and agreed to buy gold miner Arafura Surya Alam. In October it also unveiled a share buyback programme of up to Rp2 trillion, matched by subsidiary United Tractors.

Elsewhere in Indonesia, 49.9%-owned Tunas Ridean reported lower car sales and profits.

In Vietnam, THACO recorded higher automotive volumes, though passenger-car margins narrowed amid intensified competition. REE Corporation delivered stronger earnings on improved hydrology in its power business, with its contribution to Jardine Cycle & Carriage rising after the group lifted its stake to 41.6%.

Regional subsidiary Cycle & Carriage achieved higher profit on increased used-car sales, electric bus deliveries and stronger after-sales throughput in Singapore.

Jardine Cycle & Carriage is headquartered in Singapore and is 85% owned by Jardine Matheson.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10